Prevalence, pathophysiology, and clinical significance of post-heart transplant atrial fibrillation and atrial flutter

Saeed A L Ahmari, T. Jared Bunch, Anupam Chandra, Vidhan Chandra, Keiji Ujino, Richard C. Daly, Sudhir S. Kushwaha, Brooks Sayre Edwards, Youssef F. Maalouf, James B. Seward, Christopher G. McGregor, Krishnaswamy Chandrasekaran

Research output: Contribution to journalArticle

51 Citations (Scopus)

Abstract

Background: Atrial rhythm disturbances, in particular atrial fibrillation (AF) and flutter (AFL), are common in the denervated transplanted heart. However, there is a relative paucity of data in the prevalence, mechanism of arrhythmia, and long-term significance. Objectives: (1) Determine the prevalence of AF and AFL in heart transplant patients, (2) define the echo/Doppler features associated with arrhythmia, and (3) evaluate the impact of arrhythmia on long-term survival. Methods: All patients who received an orthotopic heart transplant at the Mayo Clinic, Rochester, Minnesota, between 1988 and 2000 were included. Analysis of serial electrocardiograms and Holter monitor records provided evidence of AF or AFL development. Variables including general patient demographics, histology-proven rejection numbers and grades, results of serial coronary angiography, endomyocardial biopsy specimens, and echocardiographic studies performed at 6 weeks and 3 years after transplant were obtained to determine variables predictive of arrhythmia development. Results: There were 167 heart transplant recipients, of which 16 (9.5%) developed AF and another 25 (15.0%) developed AFL over 6.5 ± 3.4 years. Patients who developed AF or AFL had lower left ventricular (LV) ejection fractions (56.6% ± 1.6% vs 62.5% ± 1.5%, p < 0.05), higher LV end-systolic dimensions (LVESD) (33.6 ± 1.12 mm vs 29.7 ± 0.97 mm, p < 0.01), higher right atrial volume indexes (43.2 ± 12.3 ml vs 35 ± 5.3 ml, p < 0.03), lower mitral deceleration time (145 ± 8 msec vs 160 ± 12 msec, p < 0.05), and lower late mitral annulus tissue a′ velocities (0.06 ± 0.005 cm/sec vs 0.08 ± 0.01 cm/sec, p < 0.02) compared with an age- and gender-matched Sinus Rhythm Group. Grade 3 rejection was a time-dependent covariate predictor of AFL risk (hazard ratio [HR], 2.95; 95% confidence interval [CI], 1.3-6.6, p < 0.008) but not AF (HR, 2.264; 95% CI, 0.72-7.1; p = 0.10). Thirty-nine of 167 patients died: 13 in the arrhythmia group and 26 in the normal sinus rhythm group. Development of atrial dysrhythmia adversely affected the outcome in the first 5 years (p < 0.001) compared with normal sinus rhythm. Predictors of long-term mortality included AF/AFL (HR, 2.88; 95% CI, 1.38-5.96; p < 0.004), age at transplant (HR, 1.04; 95% CI, 1.00-1.07, p < 0.03), coronary artery disease (HR, 2.655; 95% CI, 1.25-5.64; p = 0.01), pre-transplant cardiac amyloidosis (HR, 5.02; 95% CI 2.37-10.62; p < 0.001), right atrial volume index (HR, 1.03; 95% CI, 1.00-10.7; p = 0.03), mitral deceleration time <160 msec (p < 0.01), and LVESD >30 mm (p < 0.04). Conclusion: Development of AF/AFL post-heart transplantation is not uncommon and is associated with decreased long-term survival. Cumulative effects of repeated moderate-to-severe (grade 3 or more) rejections that result in increased cardiac fibrosis are associated with the development of AFL, but not AF. Similarly advanced restrictive diastolic dysfunction caused by fibrosis from repeated moderate-to-severe (grade 3 or more) rejections was predominant in the patients with arrhythmia and was a marker of poor long-term outcome.

Original languageEnglish (US)
Pages (from-to)53-60
Number of pages8
JournalJournal of Heart and Lung Transplantation
Volume25
Issue number1
DOIs
StatePublished - Jan 2006

Fingerprint

Atrial Flutter
Atrial Fibrillation
Transplants
Cardiac Arrhythmias
Fibrosis
Survival
Heart Transplantation
Coronary Angiography
Stroke Volume
Histology
Electrocardiography
Demography
Biopsy

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Surgery
  • Transplantation

Cite this

Prevalence, pathophysiology, and clinical significance of post-heart transplant atrial fibrillation and atrial flutter. / Ahmari, Saeed A L; Bunch, T. Jared; Chandra, Anupam; Chandra, Vidhan; Ujino, Keiji; Daly, Richard C.; Kushwaha, Sudhir S.; Edwards, Brooks Sayre; Maalouf, Youssef F.; Seward, James B.; McGregor, Christopher G.; Chandrasekaran, Krishnaswamy.

In: Journal of Heart and Lung Transplantation, Vol. 25, No. 1, 01.2006, p. 53-60.

Research output: Contribution to journalArticle

Ahmari, SAL, Bunch, TJ, Chandra, A, Chandra, V, Ujino, K, Daly, RC, Kushwaha, SS, Edwards, BS, Maalouf, YF, Seward, JB, McGregor, CG & Chandrasekaran, K 2006, 'Prevalence, pathophysiology, and clinical significance of post-heart transplant atrial fibrillation and atrial flutter', Journal of Heart and Lung Transplantation, vol. 25, no. 1, pp. 53-60. https://doi.org/10.1016/j.healun.2005.07.017
Ahmari, Saeed A L ; Bunch, T. Jared ; Chandra, Anupam ; Chandra, Vidhan ; Ujino, Keiji ; Daly, Richard C. ; Kushwaha, Sudhir S. ; Edwards, Brooks Sayre ; Maalouf, Youssef F. ; Seward, James B. ; McGregor, Christopher G. ; Chandrasekaran, Krishnaswamy. / Prevalence, pathophysiology, and clinical significance of post-heart transplant atrial fibrillation and atrial flutter. In: Journal of Heart and Lung Transplantation. 2006 ; Vol. 25, No. 1. pp. 53-60.
@article{57039e9433184db790e6e701db2dc85e,
title = "Prevalence, pathophysiology, and clinical significance of post-heart transplant atrial fibrillation and atrial flutter",
abstract = "Background: Atrial rhythm disturbances, in particular atrial fibrillation (AF) and flutter (AFL), are common in the denervated transplanted heart. However, there is a relative paucity of data in the prevalence, mechanism of arrhythmia, and long-term significance. Objectives: (1) Determine the prevalence of AF and AFL in heart transplant patients, (2) define the echo/Doppler features associated with arrhythmia, and (3) evaluate the impact of arrhythmia on long-term survival. Methods: All patients who received an orthotopic heart transplant at the Mayo Clinic, Rochester, Minnesota, between 1988 and 2000 were included. Analysis of serial electrocardiograms and Holter monitor records provided evidence of AF or AFL development. Variables including general patient demographics, histology-proven rejection numbers and grades, results of serial coronary angiography, endomyocardial biopsy specimens, and echocardiographic studies performed at 6 weeks and 3 years after transplant were obtained to determine variables predictive of arrhythmia development. Results: There were 167 heart transplant recipients, of which 16 (9.5{\%}) developed AF and another 25 (15.0{\%}) developed AFL over 6.5 ± 3.4 years. Patients who developed AF or AFL had lower left ventricular (LV) ejection fractions (56.6{\%} ± 1.6{\%} vs 62.5{\%} ± 1.5{\%}, p < 0.05), higher LV end-systolic dimensions (LVESD) (33.6 ± 1.12 mm vs 29.7 ± 0.97 mm, p < 0.01), higher right atrial volume indexes (43.2 ± 12.3 ml vs 35 ± 5.3 ml, p < 0.03), lower mitral deceleration time (145 ± 8 msec vs 160 ± 12 msec, p < 0.05), and lower late mitral annulus tissue a′ velocities (0.06 ± 0.005 cm/sec vs 0.08 ± 0.01 cm/sec, p < 0.02) compared with an age- and gender-matched Sinus Rhythm Group. Grade 3 rejection was a time-dependent covariate predictor of AFL risk (hazard ratio [HR], 2.95; 95{\%} confidence interval [CI], 1.3-6.6, p < 0.008) but not AF (HR, 2.264; 95{\%} CI, 0.72-7.1; p = 0.10). Thirty-nine of 167 patients died: 13 in the arrhythmia group and 26 in the normal sinus rhythm group. Development of atrial dysrhythmia adversely affected the outcome in the first 5 years (p < 0.001) compared with normal sinus rhythm. Predictors of long-term mortality included AF/AFL (HR, 2.88; 95{\%} CI, 1.38-5.96; p < 0.004), age at transplant (HR, 1.04; 95{\%} CI, 1.00-1.07, p < 0.03), coronary artery disease (HR, 2.655; 95{\%} CI, 1.25-5.64; p = 0.01), pre-transplant cardiac amyloidosis (HR, 5.02; 95{\%} CI 2.37-10.62; p < 0.001), right atrial volume index (HR, 1.03; 95{\%} CI, 1.00-10.7; p = 0.03), mitral deceleration time <160 msec (p < 0.01), and LVESD >30 mm (p < 0.04). Conclusion: Development of AF/AFL post-heart transplantation is not uncommon and is associated with decreased long-term survival. Cumulative effects of repeated moderate-to-severe (grade 3 or more) rejections that result in increased cardiac fibrosis are associated with the development of AFL, but not AF. Similarly advanced restrictive diastolic dysfunction caused by fibrosis from repeated moderate-to-severe (grade 3 or more) rejections was predominant in the patients with arrhythmia and was a marker of poor long-term outcome.",
author = "Ahmari, {Saeed A L} and Bunch, {T. Jared} and Anupam Chandra and Vidhan Chandra and Keiji Ujino and Daly, {Richard C.} and Kushwaha, {Sudhir S.} and Edwards, {Brooks Sayre} and Maalouf, {Youssef F.} and Seward, {James B.} and McGregor, {Christopher G.} and Krishnaswamy Chandrasekaran",
year = "2006",
month = "1",
doi = "10.1016/j.healun.2005.07.017",
language = "English (US)",
volume = "25",
pages = "53--60",
journal = "Journal of Heart and Lung Transplantation",
issn = "1053-2498",
publisher = "Elsevier USA",
number = "1",

}

TY - JOUR

T1 - Prevalence, pathophysiology, and clinical significance of post-heart transplant atrial fibrillation and atrial flutter

AU - Ahmari, Saeed A L

AU - Bunch, T. Jared

AU - Chandra, Anupam

AU - Chandra, Vidhan

AU - Ujino, Keiji

AU - Daly, Richard C.

AU - Kushwaha, Sudhir S.

AU - Edwards, Brooks Sayre

AU - Maalouf, Youssef F.

AU - Seward, James B.

AU - McGregor, Christopher G.

AU - Chandrasekaran, Krishnaswamy

PY - 2006/1

Y1 - 2006/1

N2 - Background: Atrial rhythm disturbances, in particular atrial fibrillation (AF) and flutter (AFL), are common in the denervated transplanted heart. However, there is a relative paucity of data in the prevalence, mechanism of arrhythmia, and long-term significance. Objectives: (1) Determine the prevalence of AF and AFL in heart transplant patients, (2) define the echo/Doppler features associated with arrhythmia, and (3) evaluate the impact of arrhythmia on long-term survival. Methods: All patients who received an orthotopic heart transplant at the Mayo Clinic, Rochester, Minnesota, between 1988 and 2000 were included. Analysis of serial electrocardiograms and Holter monitor records provided evidence of AF or AFL development. Variables including general patient demographics, histology-proven rejection numbers and grades, results of serial coronary angiography, endomyocardial biopsy specimens, and echocardiographic studies performed at 6 weeks and 3 years after transplant were obtained to determine variables predictive of arrhythmia development. Results: There were 167 heart transplant recipients, of which 16 (9.5%) developed AF and another 25 (15.0%) developed AFL over 6.5 ± 3.4 years. Patients who developed AF or AFL had lower left ventricular (LV) ejection fractions (56.6% ± 1.6% vs 62.5% ± 1.5%, p < 0.05), higher LV end-systolic dimensions (LVESD) (33.6 ± 1.12 mm vs 29.7 ± 0.97 mm, p < 0.01), higher right atrial volume indexes (43.2 ± 12.3 ml vs 35 ± 5.3 ml, p < 0.03), lower mitral deceleration time (145 ± 8 msec vs 160 ± 12 msec, p < 0.05), and lower late mitral annulus tissue a′ velocities (0.06 ± 0.005 cm/sec vs 0.08 ± 0.01 cm/sec, p < 0.02) compared with an age- and gender-matched Sinus Rhythm Group. Grade 3 rejection was a time-dependent covariate predictor of AFL risk (hazard ratio [HR], 2.95; 95% confidence interval [CI], 1.3-6.6, p < 0.008) but not AF (HR, 2.264; 95% CI, 0.72-7.1; p = 0.10). Thirty-nine of 167 patients died: 13 in the arrhythmia group and 26 in the normal sinus rhythm group. Development of atrial dysrhythmia adversely affected the outcome in the first 5 years (p < 0.001) compared with normal sinus rhythm. Predictors of long-term mortality included AF/AFL (HR, 2.88; 95% CI, 1.38-5.96; p < 0.004), age at transplant (HR, 1.04; 95% CI, 1.00-1.07, p < 0.03), coronary artery disease (HR, 2.655; 95% CI, 1.25-5.64; p = 0.01), pre-transplant cardiac amyloidosis (HR, 5.02; 95% CI 2.37-10.62; p < 0.001), right atrial volume index (HR, 1.03; 95% CI, 1.00-10.7; p = 0.03), mitral deceleration time <160 msec (p < 0.01), and LVESD >30 mm (p < 0.04). Conclusion: Development of AF/AFL post-heart transplantation is not uncommon and is associated with decreased long-term survival. Cumulative effects of repeated moderate-to-severe (grade 3 or more) rejections that result in increased cardiac fibrosis are associated with the development of AFL, but not AF. Similarly advanced restrictive diastolic dysfunction caused by fibrosis from repeated moderate-to-severe (grade 3 or more) rejections was predominant in the patients with arrhythmia and was a marker of poor long-term outcome.

AB - Background: Atrial rhythm disturbances, in particular atrial fibrillation (AF) and flutter (AFL), are common in the denervated transplanted heart. However, there is a relative paucity of data in the prevalence, mechanism of arrhythmia, and long-term significance. Objectives: (1) Determine the prevalence of AF and AFL in heart transplant patients, (2) define the echo/Doppler features associated with arrhythmia, and (3) evaluate the impact of arrhythmia on long-term survival. Methods: All patients who received an orthotopic heart transplant at the Mayo Clinic, Rochester, Minnesota, between 1988 and 2000 were included. Analysis of serial electrocardiograms and Holter monitor records provided evidence of AF or AFL development. Variables including general patient demographics, histology-proven rejection numbers and grades, results of serial coronary angiography, endomyocardial biopsy specimens, and echocardiographic studies performed at 6 weeks and 3 years after transplant were obtained to determine variables predictive of arrhythmia development. Results: There were 167 heart transplant recipients, of which 16 (9.5%) developed AF and another 25 (15.0%) developed AFL over 6.5 ± 3.4 years. Patients who developed AF or AFL had lower left ventricular (LV) ejection fractions (56.6% ± 1.6% vs 62.5% ± 1.5%, p < 0.05), higher LV end-systolic dimensions (LVESD) (33.6 ± 1.12 mm vs 29.7 ± 0.97 mm, p < 0.01), higher right atrial volume indexes (43.2 ± 12.3 ml vs 35 ± 5.3 ml, p < 0.03), lower mitral deceleration time (145 ± 8 msec vs 160 ± 12 msec, p < 0.05), and lower late mitral annulus tissue a′ velocities (0.06 ± 0.005 cm/sec vs 0.08 ± 0.01 cm/sec, p < 0.02) compared with an age- and gender-matched Sinus Rhythm Group. Grade 3 rejection was a time-dependent covariate predictor of AFL risk (hazard ratio [HR], 2.95; 95% confidence interval [CI], 1.3-6.6, p < 0.008) but not AF (HR, 2.264; 95% CI, 0.72-7.1; p = 0.10). Thirty-nine of 167 patients died: 13 in the arrhythmia group and 26 in the normal sinus rhythm group. Development of atrial dysrhythmia adversely affected the outcome in the first 5 years (p < 0.001) compared with normal sinus rhythm. Predictors of long-term mortality included AF/AFL (HR, 2.88; 95% CI, 1.38-5.96; p < 0.004), age at transplant (HR, 1.04; 95% CI, 1.00-1.07, p < 0.03), coronary artery disease (HR, 2.655; 95% CI, 1.25-5.64; p = 0.01), pre-transplant cardiac amyloidosis (HR, 5.02; 95% CI 2.37-10.62; p < 0.001), right atrial volume index (HR, 1.03; 95% CI, 1.00-10.7; p = 0.03), mitral deceleration time <160 msec (p < 0.01), and LVESD >30 mm (p < 0.04). Conclusion: Development of AF/AFL post-heart transplantation is not uncommon and is associated with decreased long-term survival. Cumulative effects of repeated moderate-to-severe (grade 3 or more) rejections that result in increased cardiac fibrosis are associated with the development of AFL, but not AF. Similarly advanced restrictive diastolic dysfunction caused by fibrosis from repeated moderate-to-severe (grade 3 or more) rejections was predominant in the patients with arrhythmia and was a marker of poor long-term outcome.

UR - http://www.scopus.com/inward/record.url?scp=30044450522&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=30044450522&partnerID=8YFLogxK

U2 - 10.1016/j.healun.2005.07.017

DO - 10.1016/j.healun.2005.07.017

M3 - Article

C2 - 16399531

AN - SCOPUS:30044450522

VL - 25

SP - 53

EP - 60

JO - Journal of Heart and Lung Transplantation

JF - Journal of Heart and Lung Transplantation

SN - 1053-2498

IS - 1

ER -